← All stocks

Vistagen Therapeutics, Inc.

VTGN Net buying
CIK 0001411685 #5233 in the set updated 21 Sep 2026
Bought (120 mo)
$18.21M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$147.15K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$147.15K
2 of 2 sales
Net
+$18.07M
+$18.07M against sales at will

By person

13 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
COMMODORE CAPITAL LP entity
10% owner
$17.96M (1)
+$17.96M
1,575,000
3.84%
$36.47M
+97.1%
Singh Shawn
President and CEO
$103.20K (1)
+$103.20K
733,548
1.79%
$16.98M
DOTSON JERROLD DUANE
VP, CFO
$93.75K (1)
−$93.75K
3,671
0.0089%
$84.99K
Venrock Healthcare Capital Partners II, L.P. entity
10% owner
$53.40K (1)
−$53.40K
20,637,286
50.30%
$477.82M
−0.3%
Adler Reid G.
Chief Legal Officer
$50.91K (1)
+$50.91K
60,868
0.1483%
$1.41M
SAXE JON S
Director
$45.99K (3)
+$45.99K
55,751
0.1359%
$1.29M
+2,872%
GIN JERRY B
Director
$35.74K (4)
+$35.74K
350,000
0.8530%
$8.10M
+600.0%
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER
$15.34K (2)
+$15.34K
133,500
0.3254%
$3.09M
+40.7%
Smith Mark Alan
CHIEF MEDICAL OFFICER
19,915
0.0485%
$461.09K
Prince Joshua S.
Chief Operating Officer
15,249
0.0372%
$353.06K
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
12,801
0.0312%
$296.38K
Tressler Nick B.
Chief Financial Officer
11,712
0.0285%
$271.17K
Underdown Brian J.
Director
2,500
0.0061%
$57.88K
Insider
Date
Role
Action
Shares
Price
Amount
Venrock Healthcare Capital Partners II, L.P.
12 Jul 2022
10% owner
Sell indirect
60,000
$0.89
$53.40K
DOTSON JERROLD DUANE
7 Sep 2021
VP, CFO AND SECRETARY
Sell
30,000
$3.13
$93.75K

What was left out

Form 4 filings counted 190
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 2
Shares from compensation/vesting 480,787
Sales filed before the plan box existed 2
History held since 10 Nov 2016